Involvement of diacylglycerol produced by phospholipase D activation in Aβ-induced reduction of sAPPα secretion in SH-SY5Y neuroblastoma cells.

作者: Fuminori Tanabe , Tomoko Nakajima , Masahiko Ito

DOI: 10.1016/J.BBRC.2014.03.038

关键词:

摘要: Abstract We previously reported that the thiol proteinase inhibitor, E-64-d, ameliorated amyloid β (Aβ)-induced reduction of soluble precursor protein α (sAPPα) secretion by reversing ceramide-induced kinase C down-regulation in SH-SY5Y neuroblastoma cells. In present study, we showed Aβ (1–42) peptide enhanced diacylglycerol (DAG) production phospholipase D (PLD) activation these subsequently examined whether PLD was involved Aβ-induced sAPPα and 2 μM CAY10593, which selectively inhibits PLD2, secretion, whereas 50 nM PLD1, did not. Moreover, 50 µM propranolol, a phosphatidic acid phosphohydrolase also suggesting DAG may be responsible for sAPPα. affects analog reduced addition, ceramide stimulating neutral sphingomyelinase (N-SMase) activity. demonstrated stimulates N-SMase activity Here, inhibition PLD2 CAY10593 suppressed activation. Taken together, results suggest produced through pathway is

参考文章(30)
Sarah A Scott, Paige E Selvy, Jason R Buck, Hyekyung P Cho, Tracy L Criswell, Ashley L Thomas, Michelle D Armstrong, Carlos L Arteaga, Craig W Lindsley, H Alex Brown, Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasiveness Nature Chemical Biology. ,vol. 5, pp. 108- 117 ,(2009) , 10.1038/NCHEMBIO.140
T. G. Oliveira, R. B. Chan, H. Tian, M. Laredo, G. Shui, A. Staniszewski, H. Zhang, L. Wang, T.-W. Kim, K. E. Duff, M. R. Wenk, O. Arancio, G. Di Paolo, Phospholipase D2 Ablation Ameliorates Alzheimer's Disease-Linked Synaptic Dysfunction and Cognitive Deficits The Journal of Neuroscience. ,vol. 30, pp. 16419- 16428 ,(2010) , 10.1523/JNEUROSCI.3317-10.2010
Hiroshi Watanabe, Tsunaki Hongu, Masakazu Yamazaki, Yasunori Kanaho, Phospholipase D2 activation by p38 MAP kinase is involved in neurite outgrowth Biochemical and Biophysical Research Communications. ,vol. 413, pp. 288- 293 ,(2011) , 10.1016/J.BBRC.2011.08.088
Lawrence O. Olala, Mutsa Seremwe, Ying-Ying Tsai, Wendy B. Bollag, A role for phospholipase D in angiotensin II-induced protein kinase D activation in adrenal glomerulosa cell models. Molecular and Cellular Endocrinology. ,vol. 366, pp. 31- 37 ,(2013) , 10.1016/J.MCE.2012.11.008
R. M. Nitsch, J. K. Blusztajn, A. G. Pittas, B. E. Slack, J. H. Growdon, R. J. Wurtman, Evidence for a membrane defect in Alzheimer disease brain. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 89, pp. 1671- 1675 ,(1992) , 10.1073/PNAS.89.5.1671
Michelle M. Mielke, Constantine G. Lyketsos, Alterations of the Sphingolipid Pathway in Alzheimer’s Disease: New Biomarkers and Treatment Targets? NeuroMolecular Medicine. ,vol. 12, pp. 331- 340 ,(2010) , 10.1007/S12017-010-8121-Y
Robin B. Chan, Tiago G. Oliveira, Etty P. Cortes, Lawrence S. Honig, Karen E. Duff, Scott A. Small, Markus R. Wenk, Guanghou Shui, Gilbert Di Paolo, Comparative lipidomic analysis of mouse and human brain with Alzheimer disease. Journal of Biological Chemistry. ,vol. 287, pp. 2678- 2688 ,(2012) , 10.1074/JBC.M111.274142